Back to News

Activist Investing Today: V&E's Elbaum on Covid-19 vs. 2008

Published: June 22nd, 2020
The co-head of the shareholder activism practice at Vinson & Elkins explains what the 2008 financial crisis can teach us about how activists might react and perform during the coronavirus outbreak.

As market volatility proliferates in the wake of the coronavirus outbreak, many funds of all shapes, sizes and ilks that had contemplated activism are likely to walk away. Meanwhile, established activist investors such as Carl Icahn will build stakes and pursue insurgencies.

That’s the lay of the land for activism during the unfolding pandemic of Covid-19, the disease caused by a novel coronavirus, according to Lawrence Elbaum, partner and co-head of Vinson & Elkins LLP’s shareholder activism practice.

“There will be plenty of hedge funds, first-time activists, family offices, private equity funds, who have been contemplating activism this season who are going to walk away from campaigns due to a host of pressures,” Elbaum said. “Some will be external, market-driven pressures: ‘It is too expensive to run a campaign, unlock value, this is not the time or industry to run a fight.'”

Elbaum on The Deal’s Activist Investing Today podcast spoke about why some activists will double down on their campaigns while others will cancel their efforts. He also discussed what the 2008 financial crisis and subsequent months can teach us about how activists might perform in the months to come and what steps companies trading at severe discounts to intrinsic value can do to fend off opportunistic activists, unsolicited acquirers or, in some cases, both.

Elbaum, however, also suggested that institutional activists who have “seen this movie before” will likely launch new campaigns and press forward with current campaigns.

“They don’t want to be looked at as giving up a campaign over something that might be viewed in hindsight as episodic hysteria over coronavirus or potential macro changes in energy price environment.”

Here’s the podcast:

More podcasts from The Deal are available on iTunesSpotifySoundCloud and on

More From Activism


Webcast: Pills, CEOs Get Dose of Covid-Era Scrutiny

By Tom Terrarosa
Published: July 14th, 2020
A July 9 panel hosted by The Deal illustrated that activists and advisers largely agree execs should have shared in Covid-19 market pain, but that poison pills are tricky business.

Cevian Opens Dialogue With Pearson

By Chris Nolter
Published: June 19th, 2020
The educational publisher counts Swedish activist Cevian Capital among its shareholder rolls.